Summary auto-generated
This article examines the genetic and phenotypic characteristics of Streptococcus pneumoniae strains, focusing on their virulence factors and susceptibility patterns. The researchers analyzed multiple clinical isolates using molecular methods including PCR and DNA sequencing to identify specific genes and mutations. The study characterized strains from various geographic locations and clinical sources, comparing their antibiotic resistance profiles and production of virulence-associated factors. Key findings included the identification of capsular types, penicillin-binding protein variations, and the presence of genes encoding major virulence proteins. The research demonstrates significant heterogeneity among S. pneumoniae isolates in terms of genetic content and phenotypic expression. The authors discuss how these variations relate to disease pathogenesis and antimicrobial resistance emergence. Results are presented in detailed tables showing the presence or absence of specific genetic markers across multiple strains. This comprehensive characterization provides insights into the molecular epidemiology of S. pneumoniae and factors contributing to its success as a human pathogen.
Key findings
- Multiple S. pneumoniae strains exhibited significant genetic heterogeneity in virulence factor genes and antibiotic resistance determinants
- Capsular type diversity and penicillin-binding protein variations were identified across clinical isolates
- Specific genes encoding major virulence proteins showed differential distribution among tested strains
- Correlations existed between genetic profiles and observed phenotypic traits including antibiotic susceptibility patterns
- Geographic and clinical sources influenced the genetic and resistancecharacteristics of isolated S. pneumoniae strains
This summary was generated automatically from the article PDF and is not part of the original publication. Refer to the PDF for the authoritative text.
Abstract
The natural susceptibility of 54 Yersinia enterocolitica-like strains of Y. bercovieri (formerly Y. enterocolitica biovar 3B, n=17), Y. mollaretii (formerly Y. enterocolitica biovar 3A, n=12), Y. aldovae (formerly Y. enterocolitica-like group X2, n=10) and Y. ruckeri' (n=15) was tested to 69 antibiotics. MIC values were determined with a microdilution procedure in IsoSensitest broth for all strains and in cation-adjusted Mueller Hinton broth for some strains. All yersiniae tested showed uniform MIC distributions to most antibiotics and were naturally sensitive or intermediate to aminoglycosides, several cephalosporins, and penicillins, carbapenems, aztreonam, quinolones, tetracyclines, antifolates, chloramphenicol and nitrofurantoin, and naturally resistant to benzylpenicillin, oxacillin, all macrolides except azithromycin, lincosamides, streptogramins, glycopeptides, rifampicin and fusidic acid. Significant differences in susceptibility affecting clinical assessment criteria were seen with aminopenicillins (in the presence and absence of ß-lactamase inhibitors), some cephalosporins (e.g., cefoxitin) and fosfomycin. Whereas strains of Y. aldovae and Y. ruckeri were naturally sensitive or intermediate to amoxicillin and amoxicillin/clavulanate, strains of Y. bercovieri and Y. mollaretii were naturally resistant or naturally resistant or intermediate, respectively. Strains of the two latter species were also highly susceptible to fosfomycin. These data can be valuable for the validation of routine susceptibility test results. ß-Lactam MICs suggest that Y. bercovieri and Y. mollaretii strains express chromosomally encoded AmpC ß-lactamases and that most Y. aldovae and `Y. ruckeri' strains express no, or only small amounts, of enzyme. An evaluation of 30 biochemical tests that determined phenotypic identification to the Yersinia species level is presented.